Trial Profile
A Phase II trial of PAN-301-1
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 06 Feb 2018
Price :
$35
*
At a glance
- Drugs SNS 301 (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 06 Feb 2018 New trial record
- 01 Feb 2018 According to a Panacea Pharmaceuticals media release, the company anticipates initiating this trial in the second half of 2018.